Key result
Ginsenoside Rg1 promotes angiogenesis via PI3K-Akt signaling, whereas ginsenoside Rb1 inhibits endothelial cell chemoinvasion.
Answers are grounded in this paper and cite their sources.
BACKGROUND: Ginseng is a commonly used nutraceutical. Intriguingly, existing literature reports both wound-healing and antitumor effects of ginseng extract through opposing activities on the vascular system. To elucidate this perplexity, we merged a chemical fingerprinting approach with a deconstructional study of the effects of pure molecules from ginseng extract on angiogenesis. METHODS AND RESULTS: A mass spectrometric compositional analysis of American, Chinese and Korean, and Sanqi ginseng revealed distinct "sterol ginsenoside" fingerprints, especially in the ratio between a triol, Rg1, and a diol, Rb1, the 2 most prevalent constituents. Using a Matrigel implant model and reconstituting the extracts using distinct ratios of the 2 ginsenosides, we demonstrate that the dominance of Rg1 leads to angiogenesis, whereas Rb1 exerts an opposing effect. Rg1 also promoted functional neovascularization into a polymer scaffold in vivo and the proliferation of, chemoinvasion of, and tubulogenesis by endothelial cells in vitro, an effect mediated through the expression of nitric oxide synthase and the phosphatidylinositol-3 kinase-->Akt pathway. In contrast, Rb1 inhibited the earliest step in angiogenesis, the chemoinvasion of endothelial cells. CONCLUSIONS: The present study explains, for the first time, the ambiguity about the effects of ginseng in vascular pathophysiology based on the existence of opposing active principles in the extract. We also unraveled a speciogeographic variation impinging on the compositional fingerprint that may modulate the final phenotype. This emphasizes the need for regulations standardizing herbal therapy, currently under the Dietary Supplement and Health Education Act. Furthermore, we propose that Rg1 could be a prototype for a novel group of nonpeptide molecules that can induce therapeutic angiogenesis, such as in wound healing.
No takes yet. Share an insight, caveat, or question.
Sengupta et al. (2004) studied Angiogenesis / Vascular pathophysiology. Ginsenoside Rg1 vs. Ginsenoside Rb1 was evaluated on Angiogenesis, neovascularization, and endothelial cell proliferation, chemoinvasion, and tubulogenesis. Ginsenoside Rg1 dominance promoted angiogenesis via the PI3K-Akt and nitric oxide synthase pathways, whereas ginsenoside Rb1 inhibited endothelial cell chemoinvasion.
Synapse has enriched 10 related papers. Consider them for comparative context: